Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome
| Autor: | Dale, David C. *, Firkin, Frank, Bolyard, Audrey Anna, Kelley, Merideth, Makaryan, Vahagn, Gorelick, Kenneth J., Ebrahim, Tarek, Garg, Varun, Tang, Weihua, Jiang, Honghua, Skerlj, Renato, Beaussant Cohen, Sarah |
|---|---|
| Zdroj: | In Blood 24 December 2020 136(26):2994-3003 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|